Wikidata entity: Q415752
C₁₉H₂₆N₂S (P274)
Quantities
| P4250 | defined daily dose | 3 |
| P2067 | mass | 314.18167 |
| P233 | canonical SMILES | String | CCCN1CC(CC2C1CC3=CNC4=CC=CC2=C34)CSC | ??? |
| P373 | Commons category | String | Pergolide | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | CCCN1C[C@@H](C[C@H]2[C@H]1CC3=CNC4=CC=CC2=C34)CSC | ??? |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P8026 | LiverTox likelihood score | ... | Q83284878 (Լյարդի ախտահարման հավանականության E կատեգորիա) | Լյարդի ախտահարման հավանականության E կատեգորիա |
| P2175 | medical condition treated | ... | Q11085 (Parkinson's disease) | Parkinson's disease |
| P2175 | medical condition treated | ... | Q191779 (Tourette syndrome) | Tourette syndrome |
| P129 | physically interacts with | ... | Q288797 (5-hydroxytryptamine receptor 1B) | 5-hydroxytryptamine receptor 1B |
| P129 | physically interacts with | ... | Q308856 (Dopamine receptor D4) | Dopamine receptor D4 |
| P129 | physically interacts with | ... | Q1949517 (5-hydroxytryptamine receptor 2A) | 5-hydroxytryptamine receptor 2A |
| P129 | physically interacts with | ... | Q2034004 (Dopamine receptor D2) | Dopamine receptor D2 |
| P129 | physically interacts with | ... | Q21115046 (5-hydroxytryptamine receptor 1D) | 5-hydroxytryptamine receptor 1D |
| P129 | physically interacts with | ... | Q21131500 (Dopamine receptor D5) | Dopamine receptor D5 |
| P129 | physically interacts with | ... | Q21141045 (Adrenoceptor alpha 2B) | Adrenoceptor alpha 2B |
| P129 | physically interacts with | ... | Q4639596 (5-hydroxytryptamine receptor 2B) | 5-hydroxytryptamine receptor 2B |
| P129 | physically interacts with | ... | Q4734891 (Adrenoceptor alpha 2C) | Adrenoceptor alpha 2C |
| P129 | physically interacts with | ... | Q4734892 (Adrenoceptor alpha 2A) | Adrenoceptor alpha 2A |
| P129 | physically interacts with | ... | Q21108118 (5-hydroxytryptamine receptor 2C) | 5-hydroxytryptamine receptor 2C |
| P129 | physically interacts with | ... | Q21110867 (Dopamine receptor D1) | Dopamine receptor D1 |
| P129 | physically interacts with | ... | Q21110872 (Dopamine receptor D3) | Dopamine receptor D3 |
| P129 | physically interacts with | ... | Q21115043 (5-hydroxytryptamine receptor 1A) | 5-hydroxytryptamine receptor 1A |
| P769 | significant drug interaction | ... | Q422418 ((RS)-sulpiride) | (RS)-sulpiride |
| P279 | subclass of | ... | Q12748271 (ergot alkaloids) | ergot alkaloids |
| P2868 | subject has role | ... | Q600203 (dopamine agonist) | dopamine agonist |
| P2868 | subject has role | ... | Q3579672 (antiparkinson) | antiparkinson |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | pergolide | ??? |
Why not click here or view trends?
log id: 2636030